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Common fragile sites are specific regions in the
human genome that are particularly prone to genomic
instability under conditions of replicative stress.
Recent data suggest that these sites depend on the
checkpoint kinase ATR to maintain their stability.
Genome stability is critical for limiting progression to
cancer. Several forms of genomic instability have
been described, but it has been known for years that
certain genomic loci, known as common fragile sites,
are hot spots that are more susceptible to breakage,
rearrangement and deletion than other sites [1]. Until
recently, little was known about the molecular basis
underlying the instability of fragile sites. Now, a recent
study from Casper, Nghiem, Arlt and Glover [2] sug-
gests that the stability of these sites is controlled by
the checkpoint kinase ATR, and a second study by
Baltimore [3] provides some insight into ATR’s role in
this stabilization.
Common fragile sites are found on most if not all
human chromosomes [1,4], and are said to be
‘expressed’ when they exhibit cytogenetic abnormali-
ties that appear as gaps or breaks on metaphase
chromosomes. The ‘sites’ are actually large regions of
DNA, sometimes up to 2 Mb in size, over which the
breaks and gaps form. Approximately 80 common
fragile sites have been identified, but sequence analy-
ses reveal no characteristics of these regions that
might explain their instability. Fragile site expression
is rare in cultured human cells, but can be triggered by
treatment of cells with agents that slightly delay repli-
cation fork progression, such as very low doses of the
DNA polymerase inhibitor aphidicolin. The prevailing
hypothesis is that fragile site regions are inherently dif-
ficult to replicate, so that even low doses of replication
inhibitors lead to stalling of the replication fork.
Previous observations suggested that components
of the DNA replication checkpoint, thought to coordi-
nate cell cycle events with the completion of DNA syn-
thesis and repair of DNA damage [5], might play a role
in protecting fragile sites from instability. The first of
these observations was that treatment of cells with
caffeine increases fragile site expression [6]. Caffeine
is an inhibitor of ATR, a kinase central to activation of
the replication checkpoint [5]. The second observation
was the phenotype of ATR-deficient mice, which die
early in development. Examination of ATR-deficient
blastocysts revealed extensive chromosomal frag-
mentation even in the absence of exogenous stress,
suggesting that ATR is required for genomic stability
[7]. More recently, Mec1, a homolog of ATR in Sac-
charomyces cerevisiae, was found to be important for
maintenance of genomic stability [8]. In this study,
specific chromosomal regions known as ‘replication
slow zones’ were found to replicate more slowly than
other regions and become prone to chromosome
breakage when Mec1 is lost. This raises the possibil-
ity that replication slow zones are analogous to
common fragile sites, and taken together with the
earlier observations suggests that ATR may play a role
in stabilizing fragile sites.
Recently, Casper et al. examined a possible role for
ATR in the expression of common fragile sites. Taking
advantage of ATR-deficient cells, siRNA techniques
and a dominant negative ATR mutant, they found that
absence of ATR function increased the average number
of chromosome breaks induced by low doses of aphidi-
colin by 10–20 fold, depending on the method used.
Moreover, using specific probes they found that the
number of breaks at three individual common fragile
sites increased by a similar degree. These results indi-
cate that the observed increase in fragile site expres-
sion is not due to a global defect in genomic stability.
Perhaps even more significant, the authors found that
expression of fragile sites increased when ATR function
was lost even in the absence of aphidicolin. Similar to
the chromosomal fragmentation observed in ATR-defi-
cient blastocysts, this observation argues that ATR may
be needed to stabilize these regions in the absence of
extrinsic threats to the genome.
These results provide the first evidence that expres-
sion of common fragile sites is actively prevented by
ATR. But how loss of ATR leads to abnormalities at
these sites is not known. At least two models for
ATR’s role in this process are possible. One model
suggests that ATR is required to prevent cell cycle
progression until normal DNA replication is completed
(Figure 1A). This was suggested by previous studies in
yeast, Drosophila and Xenopus model systems, where
ATR homologs are necessary to prevent cell cycle
progression when replication is blocked by inhibitors
[5,9,10]. Thus, if replication in a fragile site region were
not complete and the checkpoint was not activated
due to the absence of ATR, the cell could move into
mitosis with large unreplicated regions of DNA. At this
point, the fragile site might be expressed as a gap in
the chromosome or alternatively as a break that
results from the stresses induced during chromatin
condensation and segregation.
An alternative, though not mutually exclusive, model
to explain the effect of ATR loss on fragile site expres-
sion involves a possible role for ATR in stabilizing
stalled replication forks (Figure 1B). This role was orig-
inally proposed for the ATR homologs in yeast, Rad3
(S. pombe) and Mec1 (S. cerevisiae), and their down-
stream effectors [11,12]. The idea was dramatically
illustrated in yeast deficient in a downstream effector
of Mec1 called Rad53 [13]. These mutant cells were
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treated with hydroxyurea, and analysis of the stalled
replication forks revealed the accumulation of two
types of replication intermediates: those with exten-
sive regions of single-stranded DNA and those with
reversed forks or so-called chicken foot structures.
These structures were not observed in wild-type cells
under the same conditions, suggesting they are nor-
mally suppressed or actively resolved by the Rad53-
dependent pathway.
How might the formation of these structures be
related to the expression of fragile sites? It is thought
that fragile sites arise from the presence of single-
stranded gaps or breaks at susceptible loci during
mitosis. Thus, if extensive regions of single-stranded
DNA accumulate at stalled replication forks in ATR-
deficient cells as they do in Rad53-deficient cells,
fragile sites might be observed upon progression into
mitosis either from breakage of the DNA or from the
persistence of single-stranded gaps in the mitotic
chromosomes. Alternatively, structures similar to the
reversed forks seen in Rad53-deficient yeast could be
responsible for fragile site expression in mammalian
cells lacking ATR if these structures are processed into
double-strand breaks that persist in mitosis. In fact,
studies in E. coli and yeast suggest that reestablish-
ment of a replication fork from a reversed fork struc-
ture can be accomplished in one of two ways, one of
which could lead to a double-strand break [11,12]. 
The first, non-recombinogenic, process involves the
action of a helicase, which by regression of the
reversed fork could reestablish the replication fork
without strand cleavage, thus preventing a potential
genomic rearrangement. The second, recombino-
genic, process is based on the similarity of the
reversed fork to a Holliday junction (HJ), a key inter-
mediate in the process of homologous recombination.
In this scenario, the reversed fork would be cleaved by
a HJ resolvase or similar endonuclease to generate a
double-strand break. At this point strand invasion
would be necessary for replication restart.
The generation of a double-strand break in the
context of replication could be dangerous, and it has
been hypothesized that when replication forks stall,
Rad53, through the action of Mec1, may act to prevent
the formation of reversed forks or promote their resolu-
tion through helicase action rather than cleavage of the
Holliday junction [11,12]. By analogy then, ATR could
be acting to direct the processes of DNA repair and
replication restart, effectively preventing potentially
dangerous forms of DNA repair from occurring during
DNA replication and promoting safer alternatives.
The recent results from Brown and Baltimore seem to
favor the second model shown in Figure 1. In this study,
aphidicolin induced a significant increase in H2AX
phosphorylation in synchronized ATR-deficient cells,
but not wild-type cells, within one hour of treatment.
Since H2AX phosphorylation is a marker for double-
strand breaks, the findings indicate that double-strand
breaks are formed rapidly in ATR-deficient cells upon
aphidicolin treatment. Notably, it was necessary to
remove the aphidicolin from the ATR-deficient cells in
order for the cells to move into mitosis, where the
breaks could be observed directly. This fact indicates
that loss of ATR did not lead to mitosis in the presence
of unreplicated DNA, and is consistent with a model in
which breaks can occur prior to mitosis. Together these
results suggest that a replication checkpoint is still
intact in this ATR-deficient cell line, but that genomic
stability has been compromised.
Clearly more experiments are required to definitively
distinguish between these two models or a combina-
tion of the two. By definition, a fragile site is a cytoge-
netic abnormality observed in mitosis. Yet the obser-
vation of a fragile site in a mitotic cell does not give any
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Figure 1. Two models for ATR’s role in
expression of fragile sites.
(A) Model 1: Checkpoint failure. Loss of
ATR leads to entry into mitosis with
incompletely replicated DNA. A replication
fork’s encounter with a region that is diffi-
cult to replicate leads to ATR activation
and cell cycle arrest. In the absence of
ATR, cells do not arrest and proceed into
mitosis with regions of unreplicated DNA.
As a result, fragile sites are expressed and
represent the persistence of single-
stranded DNA or breaks that result from
entry of the unreplicated DNA into mitosis.
(B) Model 2: Replication fork collapse.
Loss of ATR leads to replication fork col-
lapse and/or inappropriate resolution of
stalled forks. A replication fork’s
encounter with a region that is difficult to
replicate leads to ATR-dependent stabi-
lization of the fork and/or proper resolution
of structures derived from the stalled fork.
In the absence of ATR, reversed forks or
structures containing large regions of
single-stranded DNA accumulate and are
inappropriately resolved. Expression of
fragile sites results from the persistence of
single-stranded DNA or breaks that form
upon resolution of these stalled forks.
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insight into the timing or nature of the molecular events
that lead to its expression. Now that we know that
fragile site expression can result from ATR loss, we
can ask which function of ATR is critical for this phe-
notype. We can also ask when the phenotypic defect
actually occurs. In this sense, the ability to look at
H2AX phosphorylation is extremely useful, as it allows
one to observe breaks at any time in the cell cycle. It
will now be important to determine if the observed
breaks actually occur at fragile sites during S phase.
Many additional questions arise from these studies.
For example, it will be of significant interest to iden-
tify the targets of ATR involved in fragile site stabi-
lization. It will also be important to determine whether
there is a general correlation between fragile sites
and loss of other checkpoint proteins. In this context,
it is interesting that loss of MSH2 and BRCA2, two
DNA repair proteins, leads to an increased frequency
in the inactivation of one particular common fragile
site [14,15]. In any event, the results of these studies
provide more credence to the idea that ATR, like its
homologs in yeast, plays a crucial role in maintaining
genomic stability.
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